Compare OGN & GLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGN | GLP |
|---|---|---|
| Founded | 1923 | 2005 |
| Country | United States | United States |
| Employees | N/A | 4700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2020 | N/A |
| Metric | OGN | GLP |
|---|---|---|
| Price | $6.11 | $46.58 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $11.75 | ★ $46.00 |
| AVG Volume (30 Days) | ★ 3.0M | 35.5K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | 1.33% | ★ 6.52% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $6,216,000,000.00 | N/A |
| Revenue This Year | $0.42 | $64.13 |
| Revenue Next Year | $1.67 | $11.74 |
| P/E Ratio | ★ $8.38 | $23.28 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.03 | $39.58 |
| 52 Week High | $15.36 | $56.59 |
| Indicator | OGN | GLP |
|---|---|---|
| Relative Strength Index (RSI) | 29.92 | 43.89 |
| Support Level | N/A | $45.78 |
| Resistance Level | $7.87 | $48.73 |
| Average True Range (ATR) | 0.21 | 1.24 |
| MACD | -0.01 | -0.18 |
| Stochastic Oscillator | 26.54 | 28.25 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.